TRIMTECH Therapeutics
Develops therapeutics focused on neurodegenerative diseases, with seed funding supporting research from its Cambridge base.
Overview
TRIMTECH Therapeutics is a Cambridge-based biotechnology company working on therapeutics for neurodegenerative diseases. Its target market includes patients, clinicians and research partners focused on conditions involving progressive neurological decline. The company is categorized here as Deep Tech rather than AI because the disclosed round information describes neurodegenerative disease therapeutics, not AI software or infrastructure. It announced a seed financing round in June 2026, with the provided funding context citing $14 million raised and a headline referencing seed funding brought to €41 million.
Funding History
Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work
Frequently Asked Questions
- How much has TRIMTECH Therapeutics raised in total?
- TRIMTECH Therapeutics has raised a total of $14M across 1 funding round.
- Who are TRIMTECH Therapeutics's investors?
- TRIMTECH Therapeutics's investors include Undisclosed.
- What does TRIMTECH Therapeutics do?
- TRIMTECH Therapeutics is a Cambridge-based biotechnology company working on therapeutics for neurodegenerative diseases. Its target market includes patients, clinicians and research partners focused on conditions involving progressive neurological decline. The company is categorized here as Deep Tech rather than AI because the disclosed round information describes neurodegenerative disease therapeutics, not AI software or infrastructure. It announced a seed financing round in June 2026, with the provided funding context citing $14 million raised and a headline referencing seed funding brought to €41 million.
- Where is TRIMTECH Therapeutics headquartered?
- TRIMTECH Therapeutics is headquartered in Cambridge, United Kingdom.
Investors
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Every AI funding round in June 2026—from Lovable's $12B raise to top fintech, infrastructure & enterprise deals. Updated daily with VCs, valuations & trends.